openPR Logo
Press release

Neuropeptide Y Acetate Market Healthcare Industry to Remain Key End-use; Vital Advantages to Boost Demand through 2026 With Global Players Amgen, Inc., Phoenix Pharmaceuticals, Inc., Sigma Aldrich Corporation, Eli Lilly & Co, Pfizer

02-12-2019 02:36 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Global Neuropeptide Y Acetate Market

Global Neuropeptide Y Acetate Market

Neuropeptide Y (NPY), a peptide with 36-amino acids, acts as a neurotransmitter in the autonomic nervous system (ANS). It is one of the most abundant neuropeptides in the central and peripheral nervous system. In the periphery, NPY is widely distributed in the adrenal medulla, in the sympathetic nerves, platelets, and various cell types within white adipose tissue. NPY in the central nervous systems is found in highest concentration within the brain stem, hypothalamus, and anterior pituitary. In spite of the major improvements and simplifications in peptide synthesis over the last few years, a considerable amount of skill is still involved in development of neuropeptide Y. Neuropeptide Y (NPY) is a potent neurotransmitter in reproductive endocrine functions regulating stress, eating behavior, and metabolism. Considerable progress has been made in understanding the role of NPY and its receptors in various disorders. The synthesis of NPY antagonists is difficult, elusive, and a time consuming task.

For In depth Information Get Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/48

Neuropeptide Y Acetate Market Taxonomy

The global neuropeptide Y acetate market can be segmented on the basis of disease, application, and geography. On the basis of application, the global neuropeptide Y acetate market is classified into following categories - food intake, obesity, stress and diet, alcoholism, and receptors. The effect on food intake is due to its innervation with other appetite regulatory factors in the CNS. This results in regulating energy utilization via modulation of fat metabolism and deposition. NPY receptors (NPYRs) are distributed across the body, classified as NPYR1, NPYR2, and NPYR5, all of which are G protein coupled receptors. Besides, solid phase peptide synthesis, liquid phase peptide synthesis, and hybrid method are the different technologies used to synthesize these peptides.

Neuropeptide Y Acetate Market Dynamics

Increase in patient population suffering from metabolic disorders and cancer, rise in research and development pipeline of peptide drugs, and technological advancements are the major factors expected to propel growth of neuropeptide Y acetate market in the near future. However, complexity in peptide formulations and lack of regulatory standards pose a major challenge to the global market growth.

Neuropeptide Y Acetate Market – Drug in Use

Megestrol acetate is a synthetic, orally-active derivative of naturally occurring hormone porogesterone. It increases appetite via stimulation of neuropeptide. Megesterol acetate improves appetite as well as protein and energy intake. However, its adverse effects include dizziness, confusion, head-aches, hyperglycemia, diarrhea, thromboembolic phenomena, peripheral edema, break-through uterine bleeding, adrenal insufficiency, and adrenal suppression. It is majorly used in cachexia that occurs with a number of diseases such as advanced cancer, chronic heart failure, AIDS, rheumatoid arthritis, Crohn’s disease, chronic obstructive pulmonary disease, and renal failure. Nanocrystals of megestrol acetate can potentially address the unmet needs in treatment of anorexia-cachexia with improved bioavailability. The formulation may have the potential to produce a more rapid clinical response and significant improvements in the outcome of patients with this disorder.

Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/neuropeptide-y-acetate-market-48

Global Players:

Amgen, Inc., Phoenix Pharmaceuticals, Inc., Sigma Aldrich Corporation, Eli Lilly & Co, Pfizer, Inc., and Bachem Holding AG, Roche AG, Ipsen, Peptisyntha, Lonza, Inc., and Takeda Pharmaceuticals Company Limited are some of the key players in the global neuropeptide Y acetate market.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuropeptide Y Acetate Market Healthcare Industry to Remain Key End-use; Vital Advantages to Boost Demand through 2026 With Global Players Amgen, Inc., Phoenix Pharmaceuticals, Inc., Sigma Aldrich Corporation, Eli Lilly & Co, Pfizer here

News-ID: 1581460 • Views: 202

More Releases from Coherent Market Insights

Explosive Detection Technologies Market 2022 Growth, Share, Strategies And Globa …
According to research published by CMI, the Explosive Detection Technologies Market is estimated to be worth US$ 11,445.2 Million by 2027, with a CAGR of 7.0 % over the forecast period (2019-2027). Explosive Detection Technologies Market 2022-2027 research report from Coherent Market Insights examines the market's flow state and key components to provide an in-depth look at the market. It accurately sends important data and cutting-edge analysis to help establish a
Zero Liquid Discharge Market 2022 Insights, Share, Trends With Global Opportunit …
According to research published by Coherent Market Insights, the Zero Liquid Discharge Market is estimated to be worth US$ 1,253.08 million by 2027, with a CAGR of 8.7% over the forecast period (2019-2027). The Zero Liquid Discharge 2022-2027 research report from Coherent Market Insights examines the market's flow state and key components to provide an in-depth look at the market. It accurately sends important data and cutting-edge analysis to help establish
Refrigerated Trailer Market 2022 - Industry Share, Challenges, Opportunities And …
According to the CMI report, The global refrigerated trailer market is predicted to reach US$ 1,801.00 Million in 2019 and grow at a CAGR of 5.4 % over the next five years. This in-depth analysis of the Refrigerated Trailer Market contains comprehensive market figures as well as information on the present state of the global and regional markets. Its comprehensive study covers everything from market circumstances to pricing comparisons among big corporations,
Photonic IC Market 2022: Development Trends And Global Opportunities Forecast to …
According to a report published by Coherent Market Insights, the Photonic IC Market is estimated to be worth US$ 17,075.6 million by 2027, with a CAGR of 42.6 % over the forecast period (2020-2027). This in-depth analysis of the Photonic IC Market contains comprehensive market figures as well as information on the present state of the global and regional markets. Its comprehensive study covers everything from market circumstances to pricing comparisons

All 5 Releases


More Releases for NPY

Neuropeptide Y Receptor Type 2 in depth study and analysis published, 2017
Neuropeptide Y Receptor Type 2 Summary  Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) pipeline Target constitutes close to 5 molecules. Out of which approximately 5 molecules are developed by Companies. The molecules developed by companies in Phase I and Preclinical stages are 1 and 4 respectively. Report covers products from therapy areas Metabolic Disorders and Central Nervous System which include indications Obesity, Epilepsy, Type 1 Diabetes (Juvenile Diabetes) and
Precise Analysis on Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) Cl …
The latest report Neuropeptide Y Receptor Type 2 - Pipeline Review, H1 2017, outlays comprehensive information on the Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) targeted therapeutics development with
Neuropeptide Y Acetate Market
Neuropeptide Y (NPY), a peptide with 36-amino acids, acts as a neurotransmitter in the autonomic nervous system (ANS). It is one of the most abundant neuropeptides in the central and peripheral nervous system. In the periphery, NPY is widely distributed in the adrenal medulla, in the sympathetic nerves, platelets, and various cell types within white adipose tissue. NPY in the central nervous systems is found in highest concentration within the
Neuropeptide Y Acetate Market - Analysis And Forecast (2016-2024): Market Shares …
Neuropeptide Y (NPY), a peptide with 36-amino acids, acts as a neurotransmitter in the autonomic nervous system (ANS). It is one of the most abundant neuropeptides in the central and peripheral nervous system. In the periphery, NPY is widely distributed in the adrenal medulla, in the sympathetic nerves, platelets, and various cell types within white adipose tissue. NPY in the central nervous systems is found in highest concentration within the
Neuropeptide Y Acetate Market - Global Industry Insights, NextGen Technological …
Neuropeptide Y (NPY), a peptide with 36-amino acids, acts as a neurotransmitter in the autonomic nervous system (ANS). It is one of the most abundant neuropeptides in the central and peripheral nervous system. In the periphery, NPY is widely distributed in the adrenal medulla, in the sympathetic nerves, platelets, and various cell types within white adipose tissue. NPY in the central nervous systems is found in highest concentration within the
NEUROPEPTIDE Y ACETATE MARKET - GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND O …
Neuropeptide Y (NPY), a peptide with 36-amino acids, acts as a neurotransmitter in the autonomic nervous system (ANS). It is one of the most abundant neuropeptides in the central and peripheral nervous system. In the periphery, NPY is widely distributed in the adrenal medulla, in the sympathetic nerves, platelets, and various cell types within white adipose tissue. NPY in the central nervous systems is found in highest concentration within the